At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 88 enrolled
Drug / intervention
Total coumarin (TC) cream +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase IIb Clinical Trial (PLANTCOAT-IIb) to Evaluate the Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris
In Brief
A Phase 2 clinical trial evaluating Total coumarin (TC) cream and Vehicle for Psoriasis Vulgaris and Topical Administration. Completed, enrolled 88 participants across 2 sites.
Detailed Summary
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of a Botanical Total Coumarin Cream (TC) in Treating Patients with Psoriasis Vulgaris
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis Vulgaris, Topical Administration
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJun 2015
First PostedDec 2017
Primary CompletionMar 2018
Study CompletionJun 2018
TodayJul 2026
First PostedDec 14, 2017
Enrollment StartJun 11, 2015
Primary CompletionMar 14, 2018
Study CompletionJun 30, 2018
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 8.5 years ago
Interventions
Total coumarin (TC) creamdrug
A well-characterized botanical drug for the topical treatment of psoriasis vulgaris. The drug has been approved by the NMPA in China and has obtained an NDA following multiple clinical trials spanning phases I-III in large cohorts.
Vehicledrug
Vehicle